Home » Topics » BioWorld Science

BioWorld Science
RSS

SangStat's Thymoglobulin nearing phase III trials completion

Aug. 9, 1996

Peptech issued U.S. patent for GMDP as antiinflammatory agent

Aug. 9, 1996

American Home Products claims rapamycin compounds

Aug. 9, 1996

MGI Pharma issued Israeli marketing approval for Salagen line extension

Aug. 9, 1996

Immunostimulant series described by Takeda

Aug. 9, 1996

Palauolol: A novel antiinflammatory phospholipase A2 inhibitor

Aug. 9, 1996

Niacinamide development update

Aug. 9, 1996

Japan Tobacco describes cell adhesion inhibitors

Aug. 9, 1996

MK7634 described in world patent

Aug. 9, 1996

VX-478 covered under U.S. patent for HIV/AIDS

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...